QT
IONS icon

Quantamental Technologies’s Ionis Pharmaceuticals IONS Stock Holding History

Quantamental Technologies’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,899
Closed -$305K – 555
2022
Q3 		$305K Buy
+6,899
New +$291K 0.12% 306
2022
Q1 		– Sell
-17,671
Closed -$538K – 467
2021
Q4 		$538K Buy
+17,671
New +$556K 0.27% 134
2019
Q3 		– Sell
-4,074
Closed -$262K – 1662
2019
Q2 		$262K Buy
+4,074
New +$288K 0.1% 350

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Quantamental Technologies's IONS Position: Q4 2022 in Review

Quantamental Technologies sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 6,899 shares — an estimated $305K sold.

Quantamental Technologies first reported a position in IONS in Q2 2019 and held it in 3 quarters. The position peaked at $538K in Q4 2021. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

  • Quantamental Technologies reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 6,899 Ionis Pharmaceuticals shares in Q4 2022, an estimated $305K.
  • Quantamental Technologies first reported a position in Ionis Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Quantamental Technologies's Ionis Pharmaceuticals position peaked at $538K in Q4 2021.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.